skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Index

Overcoming interference with the detection of a stable isotopically labeled microtracer in the evaluation of beclabuvir absolute bioavailability using a concomitant microtracer approach

Jiang, Hao ; Titsch, Craig ; Zeng, Jianing ; Jones, Barry ; Joyce, Philip ; Gandhi, Yash ; Turley, Wesley ; Burrell, Richard ; Aubry, Anne F ; Arnold, Mark E

Journal of pharmaceutical and biomedical analysis, 05 September 2017, Vol.143, pp.9-16 [Peer Reviewed Journal]

Full text available

View all versions
Citations Cited by
  • Title:
    Overcoming interference with the detection of a stable isotopically labeled microtracer in the evaluation of beclabuvir absolute bioavailability using a concomitant microtracer approach
  • Author: Jiang, Hao ; Titsch, Craig ; Zeng, Jianing ; Jones, Barry ; Joyce, Philip ; Gandhi, Yash ; Turley, Wesley ; Burrell, Richard ; Aubry, Anne F ; Arnold, Mark E
  • Description: The oral absolute bioavailability of beclabuvir in healthy subjects was determined using a microdose (100μg) of the stable isotopically labeled tracer via intravenous (IV) infusion started after oral dosing of beclabuvir (150mg). To simultaneously analyze the concentrations of the IV microtracer ([C]beclabuvir) and beclabuvir in plasma samples, a liquid chromatography-triple quadrupole mass spectrometry (LC-MS/MS) method was initially developed. Surprisingly beclabuvir significantly interfered with the IV microtracer detection when using the selected reaction monitoring (SRM) in the assay. An interfering component from the drug substance was observed using a high resolution mass spectrometer (HRMS). The mass-to-charge (m/z) of the interfering component was -32ppm different from the nominal value for the IV microtracer and thus could not be differentiated in the SRM assay by the unit mass resolution. To overcome this interference, we evaluated two approaches by either monitoring an alternative product ion using the SRM assay or isolating the interfering component using the parallel reaction monitoring (PRM) assay on the HRMS. This case study has demonstrated two practical approaches for overcoming interferences with the detection of stable isotopically labeled IV microtracers in the evaluation of absolute bioavailability, which provides users the flexibility in using either LC-MS/MS or HRMS to mitigate unpredicted interferences in the assay to support microtracer absolute bioavailability studies.
  • Is Part Of: Journal of pharmaceutical and biomedical analysis, 05 September 2017, Vol.143, pp.9-16
  • Identifier: E-ISSN: 1873-264X ; PMID: 28544885 Version:1 ; DOI: 10.1016/j.jpba.2017.04.030
  • Subjects: Biological Availability
  • Language: English

Searching Remote Databases, Please Wait